Profile data is unavailable for this security.
About the company
Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.
- Revenue in JPY (TTM)4.03tn
- Net income in JPY317.02bn
- LocationTakeda Pharmaceutical Co Ltd4F, 2-1-1, Nihombashihon-choCHUO-KU 103-8668JapanJPN
- Phone+81 332782111
- Fax+81 332782000
Mergers & acquisitions
|Acquired company||Deal status||Date||Date /|
|4502:TYO since |
|Nimbus Lakshmi Inc||Deal completed||13 Dec 2022||13 Dec 2022Deal completed||10.29%||6.00bn|
|Shionogi & Co Ltd-Intuniv & Vyvanse Manufacturing & Sales Business||Announced||31 Oct 2022||31 Oct 2022Announced||16.51%||--|
Data delayed at least 20 minutes, as of Jun 02 2023 07:00 BST.